Prognosis research strategy (PROGRESS) 1: A framework for researching clinical outcomes

Understanding and improving the prognosis of a disease or health condition is a priority in clinical research and practice. In this article, the authors introduce a framework of four interrelated themes in prognosis research, describe the importance of the first of these themes (understanding future outcomes in relation to current diagnostic and treatment practices), and introduce recommendations for the field of prognosis research

[1]  E. Thomas,et al.  A Prognostic Approach to Defining Chronic Pain Across a Range of Musculoskeletal Pain Sites , 2013, The Clinical journal of pain.

[2]  Richard D Riley,et al.  Prognosis research strategy (PROGRESS) 4: Stratified medicine research , 2013, BMJ : British Medical Journal.

[3]  E. Steyerberg,et al.  Prognosis Research Strategy (PROGRESS) 2: Prognostic Factor Research , 2013, PLoS medicine.

[4]  E. Steyerberg,et al.  Prognosis Research Strategy (PROGRESS) 3: Prognostic Model Research , 2013, PLoS medicine.

[5]  S. Gould.  The median isn't the message. , 2013, The virtual mentor : VM.

[6]  Y. Jan,et al.  Relationships between serum HER2 ECD, TIMP-1 and clinical outcomes in Taiwanese breast cancer , 2012, World Journal of Surgical Oncology.

[7]  Hester F. Lingsma,et al.  Large Between-Center Differences in Outcome After Moderate and Severe Traumatic Brain Injury in the International Mission on Prognosis and Clinical Trial Design in Traumatic Brain Injury (IMPACT) Study , 2011, Neurosurgery.

[8]  C. O'Neill,et al.  Adrenal incidentalomas: Risk of adrenocortical carcinoma and clinical outcomes , 2010, Journal of surgical oncology.

[9]  R. Fleming.  Equity and Excellence: liberating the NHS , 2010 .

[10]  D. Rowland,et al.  Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials. , 2010, The Lancet. Oncology.

[11]  Keith R. Abrams,et al.  Evaluating the Quality of Research into a Single Prognostic Biomarker: A Systematic Review and Meta-analysis of 83 Studies of C-Reactive Protein in Stable Coronary Artery Disease , 2010, PLoS medicine.

[12]  P. Shekelle,et al.  Will this patient develop persistent disabling low back pain? , 2010, JAMA.

[13]  M Borggrefe,et al.  Long-Term Prognosis of Patients Diagnosed With Brugada Syndrome: Results From the FINGER Brugada Syndrome Registry , 2010, Circulation.

[14]  L. Wallentin,et al.  Abstract 1428: Statin Use After Myocardial Iinfarction Improves Survival in Nearly All With Renal Dysfunction: Data From the Swedish Web-system for Enhancement and Development of Evidence-based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART) , 2009 .

[15]  E. Schernhammer,et al.  Parkinson’s disease and cancer risk: a systematic review and meta-analysis , 2010, Cancer Causes & Control.

[16]  Richard D Riley,et al.  Ten steps towards improving prognosis research , 2009, BMJ : British Medical Journal.

[17]  Kathryn M Refshauge,et al.  Prognosis for patients with chronic low back pain: inception cohort study , 2009, BMJ : British Medical Journal.

[18]  S. Normand,et al.  Reduction in acute myocardial infarction mortality in the United States: risk-standardized mortality rates from 1995-2006. , 2009, JAMA.

[19]  S. Greenfield,et al.  Comparative Effectiveness Research: A Report From the Institute of Medicine , 2009, Annals of Internal Medicine.

[20]  C. Goldsmith,et al.  How to use an article about prognosis. , 2009, Canadian journal of surgery. Journal canadien de chirurgie.

[21]  F. Harrell,et al.  Criteria for Evaluation of Novel Markers of Cardiovascular Risk: A Scientific Statement From the American Heart Association , 2009, Circulation.

[22]  David A. Hanauer,et al.  Exploring Clinical Associations Using ‘-Omics’ Based Enrichment Analyses , 2009, PloS one.

[23]  M. Kenward,et al.  Patient outcome after traumatic brain injury in high-, middle- and low-income countries: analysis of data on 8927 patients in 46 countries. , 2009, International journal of epidemiology.

[24]  Yvonne Vergouwe,et al.  Prognosis and prognostic research: what, why, and how? , 2009, BMJ : British Medical Journal.

[25]  O Steichen,et al.  [For or against diagnosis?]. , 2009, La Revue de medecine interne.

[26]  Bernard Rachet,et al.  Cancer survival in five continents: a worldwide population-based study (CONCORD). , 2008, The Lancet. Oncology.

[27]  Harlan M Krumholz,et al.  Outcomes Research: Generating Evidence for Best Practice and Policies , 2008, Circulation.

[28]  Han Repping-Wuts,et al.  Fatigue as experienced by patients with rheumatoid arthritis (RA): a qualitative study. , 2008, International journal of nursing studies.

[29]  P. Royston,et al.  Response: Re: Visualizing Length of Survival in Time-to-Event Studies: A Complement to Kaplan–Meier Plots , 2008 .

[30]  Fred S Apple,et al.  Universal definition of myocardial infarction. , 2007, Journal of the American College of Cardiology.

[31]  D. Berman,et al.  Prognostic value of multidetector coronary computed tomographic angiography for prediction of all-cause mortality. , 2007, Journal of the American College of Cardiology.

[32]  Hermann Brenner,et al.  Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. , 2007, The Lancet. Oncology.

[33]  Simon Capewell,et al.  Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. , 2007, The New England journal of medicine.

[34]  H Hemingway,et al.  Cost effectiveness of clinically appropriate decisions on alternative treatments for angina pectoris: prospective observational study , 2007, BMJ : British Medical Journal.

[35]  Elliott S Fisher,et al.  Analysis of observational studies in the presence of treatment selection bias: effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods. , 2007, JAMA.

[36]  C. Mathers,et al.  Projections of Global Mortality and Burden of Disease from 2002 to 2030 , 2006, PLoS medicine.

[37]  G. Mancia,et al.  Guidelines on the management of stable angina pectoris: executive summary: the task force on the management of stable angina pectoris of the European society of cardiology. , 2006, European heart journal.

[38]  P. Croft,et al.  The importance of symptom duration in determining prognosis , 2006, Pain.

[39]  J. Camm,et al.  [Guidelines on the management of stable angina pectoris: executive summary]. , 2006, Giornale italiano di cardiologia.

[40]  N Keiding,et al.  Individual survival time prediction using statistical models , 2005, Journal of Medical Ethics.

[41]  D. Miglioretti,et al.  A prognostic approach to defining chronic pain , 2005, Pain.

[42]  W. Sauerbrei,et al.  Reporting recommendations for tumor marker prognostic studies (REMARK). , 2005, Journal of the National Cancer Institute.

[43]  G. Watkinson,et al.  Peptic ulcer disease , 1985, Digestive Diseases and Sciences.

[44]  S. Gould.  The median isn't the message. , 2010, The Ceylon medical journal.

[45]  R. Buchbinder,et al.  Population based intervention to change back pain beliefs: three year follow up population survey , 2004, BMJ : British Medical Journal.

[46]  L. Wood,et al.  The General Practice Research Database , 2004, Drug safety.

[47]  P. Macfarlane,et al.  Prognosis of angina with and without a diagnosis: 11 year follow up in the Whitehall II prospective cohort study , 2003, BMJ : British Medical Journal.

[48]  Stephen B. Johnson,et al.  Central challenges facing the national clinical research enterprise. , 2003, JAMA.

[49]  C. Leboeuf‐Yde,et al.  Low back pain: what is the long-term course? A review of studies of general patient populations , 2003, European Spine Journal.

[50]  H. Nissen,et al.  Safety evaluation of sous vide‐processed ready meals , 2002, Letters in applied microbiology.

[51]  Rebecca S. Graves,et al.  Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice. , 2002 .

[52]  M. Wick.  Prognostic Factors in Cancer, 2nd ed. , 2002 .

[53]  R. Buchbinder,et al.  Population based intervention to change back pain beliefs and disability: three part evaluation , 2001, BMJ : British Medical Journal.

[54]  K. Kroenke,et al.  Symptoms Research: A Fertile Field , 2001, Annals of Internal Medicine.

[55]  C. Wiesemann,et al.  The significance of prognosis for a theory of medical practice , 1998, Theoretical medicine and bioethics.

[56]  Mike Clarke,et al.  Tamoxifen for early breast cancer: an overview of the randomised trials , 1998, The Lancet.

[57]  A. Silman,et al.  Outcome of low back pain in general practice: a prospective study , 1998, BMJ.

[58]  L. Goldman,et al.  The recent decline in mortality from coronary heart disease, 1980-1990. The effect of secular trends in risk factors and treatment. , 1997, JAMA.

[59]  W. Katon,et al.  Back pain in primary care: predictors of high health-care costs , 1996, Pain.

[60]  B. O'Sullivan,et al.  Prognostic Factors in Cancer , 1995, UICC International Union Against Cancer / Union Internationale Contre le Cancer.

[61]  Gordon H. Guyatt,et al.  Users' Guides to the Medical Literature: V. How to Use an Article About Prognosis , 1994 .

[62]  P Tugwell,et al.  Users' guides to the medical literature. V. How to use an article about prognosis. Evidence-Based Medicine Working Group. , 1994, JAMA.

[63]  R. Deyo,et al.  Back pain in primary care. Outcomes at 1 year. , 1993, Spine.

[64]  G. Guyatt,et al.  Users' guides to the medical literature. , 1993, JAMA.

[65]  Godfrey Fowler,et al.  THE STRATEGY OF PREVENTIVE MEDICINE , 1992 .

[66]  L. Goldman,et al.  Forecasting coronary heart disease incidence, mortality, and cost: the Coronary Heart Disease Policy Model. , 1987, American journal of public health.

[67]  J. Scadding.  Diagnosis: the clinician and the computer. , 1967, Lancet.